Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing cellular apoptosis and treating diseases like cancer and ALS.

Related Posts

Does the risk of getting long Covid increase each time ...

Sep 20, 2023

Pharma budget tightening trickles down to Doximity

Aug 11, 2023

FDA expands Veklury’s use to Covid-19 patients with sev...

Jul 17, 2023